InvestorsHub Logo
Followers 19
Posts 5612
Boards Moderated 0
Alias Born 01/04/2012

Re: Easka post# 10876

Friday, 04/17/2020 8:02:21 PM

Friday, April 17, 2020 8:02:21 PM

Post# of 15395
Easka. The orphan drug exclusivity expired .


Patents and Proprietary Rights

The FDA first approved the use of Acthar in 1952, and Acthar is no longer subject to patent protection. Acthar does have orphan drug exclusivity for its infantile spasm indication that extends until October 15, 2017 for that indication only

.

https://www.sec.gov/Archives/edgar/data/891288/000119312514264708/d755101dex991.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News